Balentine LLC Bristol Myers Squibb CO Transaction History

Balentine LLC

$3.35 Billion
Q1 2024

A detailed history of Balentine LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Balentine LLC holds 6,901 shares of BMY stock, worth $279,145. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,901

Previous 13,362 48.35%

Holding current value

$279,145

Previous $685,000 45.4%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $309,998 - $351,478	-6,461 Reduced 48.35%	6,901 $374,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $117,854 - $140,633	-2,431 Reduced 15.39%	13,362 $685,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $271,735 - $303,842	-4,694 Reduced 22.91%	15,793 $916,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $81,102 - $90,052	-1,273 Reduced 5.85%	20,487 $1.31 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $1.79 Million - $2.03 Million	-27,219 Reduced 55.57%	21,760 $1.51 Million

Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $135,384 - $160,314	1,977 Added 4.21%	48,979 $3.52 Million
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $6,454 - $3.82 Million	-49,650 Reduced 51.37%	47,002 $3.34 Million
Q2 2022 Oct 26, 2022	BUY	$72.62 - $79.98 $4.46 Million - $4.92 Million	61,475 Added 174.76%	96,652 $7.44 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $7.02 Million - $7.73 Million	96,652 New	96,652 $7.44 Million
Q1 2022 Oct 26, 2022	SELL	$61.48 - $73.72 $3.78 Million - $4.53 Million	-61,475 Reduced 63.6%	35,177 $2.57 Million
Q4 2021 Oct 26, 2022	SELL	$53.63 - $62.52 $4.45 Million - $5.18 Million	-82,886 Reduced 85.76%	13,766 $858,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $531,526 - $619,635	-9,911 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $54,495 - $63,834	921 Added 10.24%	9,911 $586,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $35,969 - $39,171	581 Added 6.91%	8,990 $601,000
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $48,006 - $53,992	809 Added 10.64%	8,409 $531,000
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $79,277 - $89,835	1,373 Added 22.05%	7,600 $471,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $13,955 - $15,464	243 Added 4.06%	6,227 $375,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $4,275 - $4,999	-78 Reduced 1.29%	5,984 $352,000
Q1 2020 May 18, 2020	BUY	$46.4 - $67.43 $82,128 - $119,351	1,770 Added 41.24%	6,062 $337,000
Q4 2019 Sep 02, 2020	SELL	$49.21 - $64.19 $609,810 - $795,442	-12,392 Reduced 74.27%	4,292 $276,000
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $4,234 - $5,020	99 Added 0.6%	16,684 $846,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $54,525 - $60,293	1,222 Added 7.95%	16,585 $752,000
Q1 2019 May 16, 2019	BUY	$45.12 - $53.8 $44,533 - $53,100	987 Added 6.87%	15,363 $733,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $554,059 - $718,482	11,363 Added 377.13%	14,376 $747,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $151,717 - $171,125	2,749 Added 1041.29%	3,013 $187,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $13,339 - $16,626	264 New	264 $15,000
Q1 2018 May 16, 2018	SELL	$59.92 - $68.98 $735,997 - $847,281	-12,283 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $959 - $1,045	-16 Reduced 0.13%	12,283 $753,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $679,273 - $783,938	12,299	12,299 $784,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account